Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human
Candida lusitaniae associated with infection in a patient with acute myelogenous leukemia developed resistance to amphotericin B during systemic treatment of the patient. The organism, when isolated initially, was inhibited by 0.31 μg of amphotericin B per ml in yeast nitrogen base agar, but when is...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1979
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352808/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/290351/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.2.123 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|